IP Verse

Actelion Pharmaceuticals patent opposition analysis

Get complete Patent Opposition Report for Actelion Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Actelion Pharmaceuticals opposed by its competitors

Explore Actelion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3897646	May 22, 2024	Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension	3
EP3256125	Jan 26, 2022	Dosing Regimen For A Selective S1P1 Receptor Agonist	2
EP3592391	Apr 21, 2021	Pharmaceutical Composition Comprising Selexipag	1
EP3300729	Oct 9, 2019	Therapeutic Compositions Containing Macitentan	3
EP2315587	Oct 25, 2017	Therapeutic Compositions Containing Macitentan	5

Top competitors of Actelion Pharmaceuticals

GENERICS UK

STADA ARZNEIMITTEL

TEVA PHARMACEUTICAL INDUSTRIES